Le Lézard
Classified in: Health
Subjects: VET, DEI

Verinetics Participates in the Veterans Health Administrations Innovation Network Greenhouse Initiative


RESEARCH TRIANGLE PARK, N.C., Jan. 4, 2022 /PRNewswire/ -- Verinetics collaborated with the Veterans' Health Administration (VHA) Innovators Network (iNET) through the Greenhouse Initiative to evaluate the DispenSecurtm system for controlled substances. VA medical centers (VAMCs) participating in the evaluation were Hines (Chicago), Western NC (Ashville), Memphis, Gulf Coast (Biloxi), and San Francisco.

DispenSecurtm is designed to improve MOUD management, optimized for methadone dispensed from opioid treatment programs (OTPs).  Verinetics designed DispenSecurtm as an IoT-enabled, advanced cloud-based system to enable "remote supervision" and autonomous dispensing deactivation. Verinetics intends that these features will help reduce demands on patients and providers and enhance evidence-based care.

VA employees at the VAMC's listed above participated in discovery interviews and provided design feedback on the DispenSecurtm system, its clinical functionality, and applicable use cases within the VHA. "Myriad themes emerged during discovery, leading to 22 significant insights and to identifying multiple use cases and applications for DispenSecurtm," said Elizabeth Williams, iNET Human Centered Design Lead.

Allison Amrhein, iNET Director of Operations said, "The Verinetics collaboration is one example of how iNET's Greenhouse Initiative provides frontline VHA employees an opportunity to participate in the experimental and collaborative nature of innovation as a process. We look forward to potential future collaboration with Verinetics."

"We designed DispenSecurtm to give people who need MOUD convenient yet controlled access to their medication," said Tom Mercolino, President & CEO, Verinetics, adding "we are grateful to the iNET team for their help validating that application and identifying important new applications to follow."

No VA endorsement is intended by this announcement.

About Verinetics - CertiRx Corporation d.b.a Verinetics mission is better control for controlled substances. Learn more at www.verinetics.com.

VHA Innovators Network - Launched in 2015 to build and empower a community of VHA employees who actively move VA forward using innovation to better serve Veterans and their families, iNET takes a ground-up approach by using the first-hand knowledge of frontline employees to identify some of VA's greatest challenges and develop both Veteran- and employee-centric solutions.

Verinetics Contact: Thomas J. Mercolino, PhD, President & CEO 
                                   [email protected] 

SOURCE VERINETICS


These press releases may also interest you

at 09:15
101 Mobility® is thrilled to announce the opening of its newest location in Eden Prairie, marking the introduction of the city's first nationally branded full-service provider of a wide range of mobility equipment. This includes stair lifts, ramps,...

at 09:15
Vibrant Wellness, a leader in specialized diagnostics and personalized health tools, announced today that its Tickborne Testing received approval from The Wadsworth Center, part of the New York State Department of Health.This approval enables Vibrant...

at 09:07
Olympus announced today that it has been awarded a contract for its advanced energy portfolio by Provista Inc. This new, nationwide agreement provides Provista members with negotiated pricing for Olympus® energy products, including the...

at 09:05
Adolescence isn't just a phase; it's a time of unparalleled growth and an opportunity for developing strengths that will influence our adult lives. Recognizing the potential of this developmental stage, Committee for Children a global nonprofit and...

at 09:00
The Prelude Network® (Prelude), the largest network of fertility clinics in North America, announced today an expansion of its partnership with Labcorp , a global leader of innovative diagnostic and biopharma laboratory services, to serve as its...

at 09:00
LISCure Biosciences, a leading clinical-stage biopharmaceutical company focused on discovering and developing innovative microbiome-based therapies,...



News published on and distributed by: